Status:

COMPLETED

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Wake Forest University Health Sciences

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions:

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

This is a multi-center 3-month study to determine the variation in ProAir Digihaler metrics \[peak inspiratory flow (PIF), inhalation volume, number of inhalation events\] amongst COPD patients in the...

Detailed Description

The albuterol sulfate electronic multidose dry powder inhaler (Albuterol eMDPI) Digital System (DS) (ProAir® Digihaler®) is the first and only Food and Drug Administration (FDA) approved inhaler rescu...

Eligibility Criteria

Inclusion

  • Age \>40 years old
  • History of cigarette smoking \>=10 pack-years
  • Established COPD defined as physician diagnosis along with spirometry confirmation \[post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC)\<0.70\] within the last two years and an FEV1 ≤80% predicted
  • Regular albuterol use (defined as at least one puff weekly for each of the last four weeks)
  • Currently non-hospitalized
  • Medical records confirmed history of two moderate AECOPD (defined as use of antibiotic or steroids to treat clinical event consistent with AECOPD) or one severe AECOPD (defined as emergency department/hospital visit) in prior 12 months
  • Access to smart phone, tablet or computer and internet
  • Willingness to switch current rescue inhaler/device to ProAir Digihaler

Exclusion

  • Allergy or inability/contraindication to use Albuterol Sulfate
  • Any condition that, in the opinion of the site investigator, would compromise the subject's ability to participate in the study

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 13 2023

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT05241288

Start Date

March 1 2022

End Date

February 13 2023

Last Update

January 23 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27514

2

Wake Forest University Baptist Medical Center

Winston-Salem, North Carolina, United States, 27157